Takeda files US trial brief in antitrust case over Amitiza
MLex Summary: Takeda Pharmaceuticals filed its US trial brief in a case accusing it of delaying a generic version of the drug Amitiza. It argued that the settlement agreement between it,...To view the full article, register now.
Already a subscriber? Click here to view full article